{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:02:28Z","timestamp":1784754148949,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":140,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gimopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine Open"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gimo.2026.104406","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:06:24Z","timestamp":1779897984000},"page":"104406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identifying and characterizing the germinal genetic landscape of men with prostate cancer: A real-life, retrospective, multicenter study"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-6502","authenticated-orcid":false,"given":"Ran","family":"Svirsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batya","family":"Sonnenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Kedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miora","family":"Linial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noy","family":"Azulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Sharabi-Nov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.gimo.2026.104406_bib1","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.3390\/cancers13092154","article-title":"Germline genetics of prostate cancer: prevalence of risk variants and clinical implications for disease management","volume":"13","author":"Doan","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.gimo.2026.104406_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/pros.23795","article-title":"The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: a meta-analysis","volume":"79","author":"Oh","year":"2019","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.gimo.2026.104406_bib3","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.gimo.2026.104406_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"16","key":"10.1016\/j.gimo.2026.104406_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gimo.2026.104406_bib6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jnci\/djaa132","article-title":"Germline sequencing DNA repair genes in 5545 men with aggressive and nonaggressive prostate cancer","volume":"113","author":"Darst","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.gimo.2026.104406_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.gimo.2026.104406_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.euo.2023.07.008","article-title":"Efficacy of National Comprehensive Cancer Network guidelines in identifying pathogenic germline variants among unselected patients with prostate cancer: the PROCLAIM trial","volume":"6","author":"Shore","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.gimo.2026.104406_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/JU.0000000000004190","article-title":"Clinician-reported management recommendations in response to universal germline genetic testing in patients with prostate cancer","volume":"212","author":"Shore","year":"2024","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.gimo.2026.104406_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1200\/OP-24-00626","article-title":"Implementation of universal germline genetic testing into standard of care for patients with prostate cancer: the time is now","volume":"21","author":"Shore","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"7","key":"10.1016\/j.gimo.2026.104406_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00695","article-title":"Retrospective cohort study on the limitations of direct-to-consumer genetic screening in hereditary breast and ovarian cancer","volume":"7","author":"Desai","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.gimo.2026.104406_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1060504","article-title":"Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis","volume":"14","author":"Anaclerio","year":"2023","journal-title":"Front Genet"},{"issue":"21","key":"10.1016\/j.gimo.2026.104406_bib12","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1200\/JCO.24.00662","article-title":"Selection of germline genetic testing panels in patients with cancer: ASCO guideline","volume":"42","author":"Tung","year":"2024","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.gimo.2026.104406_bib13","first-page":"S37","article-title":"Mismatch repair deficiency and clinical implications in prostate cancer","volume":"82","author":"Graham","year":"2022","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.gimo.2026.104406_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233260","article-title":"Mismatch repair deficiency in metastatic prostate cancer: response to PD-1 blockade and standard therapies","volume":"15","author":"Graham","year":"2020","journal-title":"PLoS One"}],"container-title":["Genetics in Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774426009167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774426009167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:07:04Z","timestamp":1784750824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949774426009167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"alternative-id":["S2949774426009167"],"URL":"https:\/\/doi.org\/10.1016\/j.gimo.2026.104406","relation":{},"ISSN":["2949-7744"],"issn-type":[{"value":"2949-7744","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying and characterizing the germinal genetic landscape of men with prostate cancer: A real-life, retrospective, multicenter study","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gimo.2026.104406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"104406"}}